GlaxoSmithKline PLC Director/PDMR Shareholding (3318X)
February 20 2017 - 8:12AM
UK Regulatory
TIDMGSK
RNS Number : 3318X
GlaxoSmithKline PLC
20 February 2017
GlaxoSmithKline plc (the 'Company')
Shares withheld or sold to meet tax liabilities
Following the vesting of the pre-tax awards granted in 2014
under the GlaxoSmithKline Deferred Annual Bonus Plan (DABP) on 16
February 2017 and as notified on 17 February 2017, the
notifications that follow reflect changes in the interests of
Persons Discharging Managerial Responsibilities (PDMRs) in American
Depositary Shares (ADSs) of the Company arising from the
withholding of ADSs to meet tax liabilities.
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================
a) Name Dr M M Slaoui
==== ========================== =============================================
b) Position/status Chairman, Global Vaccines
==== ========================== =============================================
c) Initial notification/ Initial notification
amendment
==== ========================== =============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================
a) Name GlaxoSmithKline plc
==== ========================== =============================================
b) LEI 5493000HZTVUYLO1D793
==== ========================== =============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================
a) Description of GlaxoSmithKline plc American Depositary
the financial Shares ('ADSs')
instrument ISIN: US37733W1053
==== ========================== =============================================
b) Nature of the The withholding of ADSs to meet tax liabilities
transaction further to the vesting of awards granted
in 2014 under the Company's 2009 Deferred
Annual Bonus Plan-Deferred Bonus and Matching
Awards.
==== ========================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- -----------------
$40.57 9,237 (Deferred)
--------- -----------------
$40.57 3,249 (Matching)
--------- -----------------
==== ========================== =============================================
d) Aggregated information
Aggregated volume
Price
12,486
$40.57
=============================== =============================================
e) Date of the transaction 2017-02-16
==== ========================== =============================================
f) Place of the n/a
transaction
==== ========================== =============================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==========================================================================
a) Name Mr D E Troy
==== ========================= ===============================================
b) Position/status SVP & General Counsel
==== ========================= ===============================================
c) Initial notification/ Initial notification
amendment
==== ========================= ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================
a) Name GlaxoSmithKline plc
==== ========================= ===============================================
b) LEI 5493000HZTVUYLO1D793
==== ========================= ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================
a) Description of GlaxoSmithKline plc American Depositary
the financial Shares ('ADSs')
instrument ISIN: US37733W1053
==== ========================= ===============================================
b) Nature of the The withholding of ADSs to meet tax liabilities
transaction further to the vesting of awards granted
in 2014 under the Company's 2009 Deferred
Annual Bonus Plan-Deferred Bonus and Matching
Awards.
==== ========================= ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- -----------------
$40.57 3,280 (Deferred)
--------- -----------------
$40.57 1,208 (Matching)
--------- -----------------
==== ========================= ===============================================
d) Aggregated information
Aggregated volume
Price
4,488
$40.57
============================== ===============================================
e) Date of the transaction 2017-02-16
==== ========================= ===============================================
f) Place of the n/a
transaction
==== ========================= ===============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHZBLFLDLFBBBK
(END) Dow Jones Newswires
February 20, 2017 09:12 ET (14:12 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024
